Boston Scientific (BSX) Cost of Revenue (2009 - 2026)
Boston Scientific (BSX) posted quarterly Cost of Revenue of $1.6 billion for Q2 2026, down 2.63% year-over-year from $1.6 billion in Q2 2025, and little changed on a QoQ basis from $1.6 billion in Q1 2026.
Boston Scientific (BSX) Cost of Revenue (2009 - 2026) Analysis & Trends
Boston Scientific has reported Cost of Revenue for 18 years, with the latest figure at $1.6 billion in Q2 2026.
- Cost of Revenue for Q2 2026 came in at $1.6 billion, down 2.63% year-over-year; the trailing twelve-month figure through Jun 2026 was $6.3 billion (up 7.62% YoY), and the FY2025 annual result was $6.2 billion, up 18.34% from the prior year.
- Cost of Revenue held at $1.6 billion in Q2 2026, from $1.6 billion in the prior quarter.
- Over five years, Cost of Revenue peaked at $1.6 billion in Q2 2025 and troughed at $955.0 million in Q1 2022.
- A 5-year average of $1.3 billion and a median of $1.2 billion in 2024 frame the typical range for Cost of Revenue.
- The widest annual swing landed in 2025, when Cost of Revenue rose 28.9%; it then slipped 2.63% in 2026.
- A 5-year view of Cost of Revenue shows it stood at $1.0 billion in 2022, then rose by 13.45% to $1.1 billion in 2023, then gained by 27.81% to $1.5 billion in 2024, then gained by 9.69% to $1.6 billion in 2025, then slipped by 0.87% to $1.6 billion in 2026.
- Per Business Quant data, the three most recent Cost of Revenue figures were $1.6 billion in Q2 2026, $1.6 billion in Q1 2026, and $1.6 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn | 635.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.59 Bn |
| Jun 30, 2026 | 1.59 Bn |
| Mar 31, 2026 | 12.00 Mn |
| Mar 31, 2026 | 12.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 30, 2025 | 12.00 Mn |
| Sep 30, 2025 | 12.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 1.45 Bn |
| Mar 31, 2025 | 1.45 Bn |
| Dec 31, 2024 | 5.23 Bn |
| Dec 31, 2024 | 5.23 Bn |
| Sep 30, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Mar 31, 2024 | 1.21 Bn |
| Mar 31, 2024 | 1.21 Bn |